Informations générales (source: ClinicalTrials.gov)
Effects of Cycling Workstation on Cardiometabolic Health for Workers With an Office-sitting Desk (REMOVE)
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
janvier 2020
janvier 2022
29 juin 2024
The recent literature has highlighting the importance of the time of inactivity and the
level of physical activity (PA) as predictors of metabolic cardio risks. Now, sedentary
lifestyles are well recognized as one of the causes of mortality. As with physical
activity, a dose-response relationship appears to exist: mortality would increase with
time spent in sedentary behaviors. However, this relationship would not be linear: the
more the daily sitting time increases, the more the consequences on mortality are
important. It is now well demonstrated that time spent in sedentary adult behaviour finds
primarily its origin in the work, characterized by prolonged and uninterrupted periods of
sitting. Many strategies have been settled to break the prolonged sitting time. The most
promising one seem to be the use of active workstations (treadmill, cycling, stepping)
because they reduce sedentary time at work and increase physical activity with positive
effects on the global health. If active workstations have demonstrated their
effectiveness with overweight or obese people by increasing daily energy expenditure,
their interest in prevention in normal weight people is less known. In addition, the
long-term effectiveness of a program of reactivation by active workstation on biological
parameters, quantitative and qualitative time of sedentary behaviour (duration, number of
breaks) and physical fitness was not assessed.
The main objective of this project is to study the effects of the use of a cycling
workstation for 60 minutes per day (30 minutes twice a day) for 3 months among
professionals with an office-sitting desk on overall quantity of physical activity time
(work and non-work) and sedentary time.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU de Clermont-Ferrand - 63003 - Clermont-Ferrand - France | Martine Duclos | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Healthy volunteer, male or female, between 18 and 61 years old
- Body mass index > 18,5 kg/m2 and ≤ 35 kg/m2
- More than 0.8 full time equivalent hours (FTE) with 75% of this time in a sitting
position
- Able to provide informed consent to research participation
- Registered in the French social security system
- Healthy volunteer, male or female, between 18 and 61 years old
- Body mass index > 18,5 kg/m2 and ≤ 35 kg/m2
- More than 0.8 full time equivalent hours (FTE) with 75% of this time in a sitting
position
- Able to provide informed consent to research participation
- Registered in the French social security system
- Work involving multiple periods of sitting interruptions >1 minute
- Subject using a sit-to-stand office desk or a swiss ball
- Sports activity > 2.5 hours/week
- Contact jobs (face-to-face with people)
- Pregnant or breastfeeding women
- Medical or surgical history determined by principal investigator to be not
compatible with the study
- Subject with cardiorespiratory and/or osteo-articular disorders limiting their
ability to perform physical tests or the use of active offices
- Subject with type 1 or type 2 diabetes treated with insulin
- Subject with progressive cardiovascular or neoplastic disease.
- Subject with a major infection within 3 months of inclusion.
- Subject with known neuromuscular pathology: myopathy, myasthenia, rhabdomyolysis,
paraplegia, hemiplegia
- Subject with chronic or acute inflammatory pathology 3 months prior to inclusion
- Subject treated by beta-blocker
- Subject diagnosed and/or treated for schizophrenia, bipolar disorders, major
depression
- Subject treated, or having stopped treatment for less than 3 months prior to
inclusion, by corticosteroids, immunosuppressant, anabolic, growth hormone.
- Subject with unstable psychiatric condition
- Significant alcohol consumption (> 2-3 drinks per day depending on gender) or
presence of substance abuse.
- Unable to walk or pedal 45 minutes in a row
- Subject who is excluded from another study or who received more than €4,500 in the
year following his participation in clinical studies
- Subject deprived of their liberty by judicial or administrative decision
- Refusal to sign written consent to participate
- Subject participating in another study